GlassScriptPhysician profile
Elliott Bondi
NPI 1184667487
$15,653.26
in general payments reported to CMS, 2019-2025
48 companies · $2,187 in 2025
The $2,187 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,780 · 2020: $1,385 · 2021: $1,831 · 2022: $2,772 · 2023: $2,993 · 2024: $2,705 · 2025: $2,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,805 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,804.73 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,291.29 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,845.14 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $1,566.59 | 2019-2025 | Uptravi, Opsumit |
| Insmed, INC. | $1,241.69 | 2019-2025 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $783.55 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Mallinckrodt Hospital Products INC. | $738.97 | 2020-2025 | Acthar |
| Genentech USA, INC. | $639.69 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $621.72 | 2022-2025 | Purified Cortrophin Gel |
| Harmony Biosciences LLC | $482.48 | 2022-2025 | Wakix |
| Electromed, INC. | $423.59 | 2019-2025 | Smartvest |
| Advanced Respiratory, INC | $417.18 | 2019-2021 | |
| Shionogi INC | $394.49 | 2021-2023 | Fetroja |
| Regeneron Healthcare Solutions, INC. | $390.06 | 2021-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $326.52 | 2019-2025 | Capvaxive, Winrevair |
| Inogen, INC. | $307.42 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $305.80 | 2021-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $236.44 | 2022-2024 | Aralast, Glassia |
| Amgen INC. | $187.68 | 2022-2024 | Tezspire |
| Pfizer INC. | $186.74 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $184.43 | 2019-2024 | Eliquis |
| Baxter Healthcare | $175.68 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Sunovion Pharmaceuticals INC. | $174.11 | 2019 | |
| Mallinckrodt Enterprises LLC | $149.48 | 2019 | |
| Abbvie INC. | $138.07 | 2023-2025 | Teflaro, Avycaz |
| Philips North America LLC | $135.79 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $133.83 | 2020-2022 | |
| Vapotherm INC | $127.85 | 2021-2023 | Vapotherm |
| Biomerieux INC | $103.42 | 2023 | Nephrocheck Liquid Control Kit |
| Viatris Specialty LLC | $97.34 | 2025 | Yupelri |
| Genzyme Corporation | $79.58 | 2021-2024 | |
| 3b Medical, INC. | $78.26 | 2025 | Luna |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.33 | 2024-2025 | Lifevest |
| Circassia INC. | $74.96 | 2019-2020 | |
| Chiesi USA, INC. | $65.97 | 2023-2025 | Cleviprex |
| United Therapeutics Corporation | $59.81 | 2024-2025 | Tyvaso, Tyvaso |
| Verona Pharma, INC. | $51.32 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $47.94 | 2025 | Nuzyra |
| Novartis Pharmaceuticals Corporation | $43.57 | 2021 | |
| Phadia US INC. | $42.56 | 2019-2024 | Immunocap |
| La Jolla Pharmaceutical Company | $39.61 | 2019 | |
| Allergan, INC. | $35.54 | 2019-2020 | |
| Melinta Therapeutics, LLC | $24.73 | 2019 | |
| Ucb, INC. | $23.81 | 2023 | Briviact |
| Gilead Sciences, INC. | $23.80 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.52 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.32 | 2021 | |
| Ambu INC. | $18.92 | 2020 | |
| Astellas Pharma US INC | $16.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Bondi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.